---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-014775"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2023-11-27T23:59:59+00:00"
generated_at: "2026-06-07T21:18:48.919894+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ZIVO Bioscience receives Nasdaq delisting notice; shares to trade on OTC Pink Sheets

## Summary
- Nasdaq notified ZIVO on Nov 22, 2023 of delisting for noncompliance with Listing Rule 5550(b)(1).
- Trading suspended on Nasdaq effective Nov 27, 2023; company expects to trade on OTC Pink Sheets same day under symbol ZIVO.
- Company has applied for OTCQB quotation; pending approval, shares will trade on OTC Pink Sheets.
- Transition to OTC Markets will not affect business or operations; company will continue SEC reporting.

## SEC filing metadata
- accession: 0001654954-23-014775
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2023-11-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495423014775/0001654954-23-014775-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495423014775/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-014775
- JSON: https://secwatch.observer/filing/0001654954-23-014775.json
- Plain text: https://secwatch.observer/filing/0001654954-23-014775.txt

## Key facts
- Listing & Compliance Notices
  Zivo Bioscience, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: November 22, 2023, the Company was notified by The Nasdaq Stock Market LLC (“ Nasdaq ”) that as a result of the Company’s previously disclosed noncompliance with Nasdaq Listing Rule 5550(b)(1), Nasdaq has determined to delist the Company’s common stock from the Nasdaq Capital Market and, accordingly, will suspend trading in the Company’s common stock effective at the open of business, on November 27, 2023. Nasdaq further indicated that it will file a Form 25 Notification of Delisting with the Securities and Exchange Commission (the “ SEC ”). The Company has applied to have its common stock quo
  evidence_url: https://www.sec.gov/Archives/edgar/data/1101026/000165495423014775/0001654954-23-014775-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.